Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Cell
|
March 1, 2024
Past, present, and future of CRISPR genome editing technologies
Martin Pacesa, Oana Pelea, Martin Jinek
The CRISPR Journal
|
October 7, 2022
RNA-Responsive gRNAs for Controlling CRISPR Activity: Current Advances, Future Directions, and Potential Applications
Oana Pelea, Tudor A Fulga, Tatjana Sauka-Spengler
Elife
|
July 29, 2025
Specific modulation of CRISPR transcriptional activators through RNA-sensing guide RNAs in mammalian cells and zebrafish embryos
Oana Pelea, Sarah Mayes, Quentin R V Ferry, et al.
Science (New York, N.Y.)
|
February 5, 2026
Programmable genome editing in human cells using RNA-guided bridge recombinases
Oana Pelea, András Tálas, Javier Fernández Carrera, et al.
NPJ Precision Oncology
|
April 1, 2022
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy
Timothy Rajakumar, Rastislav Horos, Julia Jehn, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Cell
|
March 1, 2024
Past, present, and future of CRISPR genome editing technologies
Martin Pacesa, Oana Pelea, Martin Jinek
The CRISPR Journal
|
October 7, 2022
RNA-Responsive gRNAs for Controlling CRISPR Activity: Current Advances, Future Directions, and Potential Applications
Oana Pelea, Tudor A Fulga, Tatjana Sauka-Spengler
Elife
|
July 29, 2025
Specific modulation of CRISPR transcriptional activators through RNA-sensing guide RNAs in mammalian cells and zebrafish embryos
Oana Pelea, Sarah Mayes, Quentin R V Ferry, et al.
Science (New York, N.Y.)
|
February 5, 2026
Programmable genome editing in human cells using RNA-guided bridge recombinases
Oana Pelea, András Tálas, Javier Fernández Carrera, et al.
NPJ Precision Oncology
|
April 1, 2022
A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy
Timothy Rajakumar, Rastislav Horos, Julia Jehn, et al.
Page
of 1